PATENT CLAIM ANALYSIS

Application Number: 16038198
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "291000"]

Abstract:
Disclosed herein are methods of using daphnoretin to treat, prevent or reduce the incidence of organ transplant rejection and graft-versus-host disease (GVHD). According to embodiments of the present disclosure, daphnoretin is administered to the recipient subject or to the donor organ prior to the transplantation to reduce immune response in the recipient subject against the transplanted organ, or to lower the risk of developing GVHD in the recipient subject.

Claim (Index 3):
The method of  claim 2 , wherein the amount of the daphnoretin is administered in the range of 1-50 mg/Kg.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13209349', '14227414', '14382537', '12322201', '14233114']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6928277435796181
- 35 USC 102 Novelty (BERT): 0.5167169286082524
- Combined Prediction Score: 0.6752166620824815
- Mean Citation Score: 140.96319
- Max Citation Score: 155.08578
- Similarity Product: 81.43544951562166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test